. 2007 Mar 20;96(8):1293–1301. doi: 10.1038/sj.bjc.6603696

Table 1. Prediction of HLA-A^*0201-restricted SOX2-derived peptides and determination of binding affinities by a competition assay.

Peptide	Positiona	Sequence	MW	Lengthb	Score	rBA (%)c
60029	275–283	SMYLPGAEV	965.5	9	26	97.2
60030	131–139	LLAPGGNSM	858.4	9	25	80.0
60031	118–127	ALSPASSRSV	1239.7	10	24	43.3

Abbreviations: MW=molecular weight; rBA=relative binding affinity.

The given numbers indicate the position of the peptide in the amino acid sequence of SOX2.

Number of amino acids.

The relative binding affinities were determined by comparing the inhibition of the reporter peptide binding by the analysed peptides in relation to the inhibition obtained with a positive control peptide, which was set as 100%. The positive control peptide was YLLPAIVHI from RNA helicase p72 and the reporter peptide was ILK(FITC)EPVHGV from HIV-1 reverse transcriptase. All peptides were used at a concentration of 10 μM.

Table 1. Prediction of HLA-A*0201-restricted SOX2-derived peptides and determination of binding affinities by a competition assay.

Table 1. Prediction of HLA-A^*0201-restricted SOX2-derived peptides and determination of binding affinities by a competition assay.